Washington Trust CO Clene Inc. Transaction History

Washington Trust CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	BUY	$0.26 - $0.55 $260 - $550	1,000 Added 50.0%	3,000 $0
Q1 2023 May 10, 2023	BUY	$0.95 - $1.62 $1,898 - $3,236	1,998 Added 99900.0%	2,000 $2,000
Q1 2023 May 04, 2023	SELL	$0.95 - $1.62 $1,898 - $3,236	-1,998 Reduced 99.9%	2 $2,000
Q3 2022 Oct 14, 2022	BUY	$0.33 - $73.0 $330 - $73,000	1,000 Added 100.0%	2,000 $6,000
Q4 2021 Feb 09, 2022	BUY	$3.95 - $7.53 $3,950 - $7,530	1,000 New	1,000 $4,000

230K

25K

Ticker CLNN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,502,000
Market Cap $273M
Description
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

Stay updated on Washington Trust CO with notifications on news.